Rocket Lab
RKLB
$72.57
-0.52%
Rocket Lab Corporation is a vertically integrated space company providing end-to-end mission services, including launch vehicles (Electron and the upcoming Neutron), spacecraft platforms (Photon), and space systems components, serving civil, defense, and commercial markets. As a leading player in the small satellite launch segment, Rocket Lab differentiates itself through frequent, reliable access to orbit and a growing space systems business, positioning it as a key competitor to larger incumbents like SpaceX. The current investor narrative centers on the company's record revenue growth and expanding backlog, driven by government contracts and the anticipated Neutron rocket debut, but is tempered by concerns over valuation, execution risks, and recent stock volatility following earnings. With a market cap of approximately $40 billion, the stock is a high-beta, high-growth play in the aerospace and defense sector, attracting both enthusiasm for its long-term potential and scrutiny over its path to profitability.…
RKLB
Rocket Lab
$72.57
Related headlines
RKLB 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rocket Lab's 12-month outlook, with a consensus price target around $112.94 and implied upside of +55.6% versus the current price.
Average Target
$112.94
0 analysts
Implied Upside
+55.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$64 - $150
Analyst target range
Rocket Lab is covered by 17 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.61 (where 1 is Strong Buy and 5 is Sell). The average target price is $112.76, implying an upside of approximately 40.5% from the current price of $80.25. The distribution shows a bullish tilt, with 10 Buy ratings, 6 Overweight/Outperform ratings, and 1 Hold, and no Sell ratings, indicating strong conviction among analysts despite recent volatility. The high target of $150.00 suggests that some analysts see significant upside, likely driven by the successful launch of Neutron and continued revenue growth, while the low target of $64.00 reflects concerns about execution risks and valuation compression. The wide range between the low and high targets (86.7% spread) underscores the high uncertainty surrounding the stock, and recent ratings actions, such as KeyBanc's upgrade from Sector Weight to Overweight in June 2026, show that sentiment is improving, though the stock's high beta of 2.63 means it will remain volatile.
Bulls vs Bears: RKLB Investment Factors
Rocket Lab presents a compelling growth story with accelerating revenue, expanding margins, and a strong backlog, but the stock's valuation is stretched to extreme levels, trading at 61.5x sales with negative earnings. The bull case rests on the successful execution of Neutron and continued revenue growth, while the bear case hinges on valuation compression and potential execution missteps. Currently, the bearish evidence is stronger due to the unsustainable valuation and high volatility, but the long-term growth potential keeps the debate balanced. The most critical tension is whether the company can grow into its valuation fast enough to justify the premium, or if the market will re-rate the stock downward.
Bullish
- Revenue growth accelerating to 63.5% YoY: Q1 2026 revenue of $200.35M grew 63.46% YoY, up from $122.57M in Q1 2025, marking the fourth consecutive quarter of accelerating growth. This demonstrates strong demand across both launch services and space systems, with the company scaling rapidly.
- Gross margin expansion of 9.4 points: Gross margin improved to 38.18% in Q1 2026 from 28.76% in Q1 2025, indicating operational leverage and better cost management. This trend suggests the company is moving toward profitability as revenue scales.
- Analyst consensus Buy with 40.5% upside: With 17 analysts, the consensus is Buy (mean score 1.61) and the average target price is $112.76, implying a 40.5% upside from the current price of $80.25. No Sell ratings and recent upgrades (e.g., KeyBanc) reflect improving sentiment.
- Record backlog and government contracts: Rocket Lab recently won a $397M Space Force contract, its largest defense contract to date, and continues to secure government deals. This provides revenue visibility and validates its technology for national security missions.
Bearish
- Extreme valuation at 61.5x sales: The PS ratio of 61.51x is astronomically higher than the aerospace & defense sector average of 2-3x, implying the market is pricing in flawless execution and massive future growth. Any disappointment could trigger a severe de-rating.
- Negative profitability and cash burn: Net income was -$45.02M in Q1 2026, with an EPS of -$0.07, and free cash flow TTM is -$316.3M. The company remains unprofitable, and continued cash burn increases reliance on external funding, which could dilute shareholders.
- High volatility with beta of 2.63: The stock's beta of 2.63 means it is highly sensitive to market swings, amplifying both gains and losses. Recent 3-month price change of -35.68% illustrates the downside risk, as the stock fell from $151 to $80.25.
- Execution risks around Neutron rocket: The Neutron rocket, critical for future growth, has faced delays. Its successful launch is not guaranteed, and any failure or further delay could severely impact the stock, given the high expectations embedded in the valuation.
RKLB Technical Analysis
Rocket Lab's stock has exhibited a dramatic uptrend over the past year, with a 1-year price change of +87.46%, significantly outperforming the S&P 500's +20.37% over the same period. However, the current price of $80.25 sits at only 53% of the 52-week range (between $37.57 and $151.00), indicating a substantial pullback from its May 2026 peak. This positioning suggests that while the long-term trend remains bullish, the stock is currently in a corrective phase, trading well below its highs and closer to the lower end of its range, which could signal either a value opportunity or a potential further decline depending on broader market sentiment.
Beta
2.63
2.63x market volatility
Max Drawdown
-61.0%
Largest decline past year
52-Week Range
$38-$151
Price range past year
Annual Return
+74.7%
Cumulative gain past year
| Period | RKLB Return | S&P 500 |
|---|---|---|
| 1m | +4.0% | +2.5% |
| 3m | -46.5% | +2.7% |
| 6m | +2.4% | +11.1% |
| 1y | +74.7% | +20.5% |
| ytd | -4.5% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RKLB Fundamental Analysis
Rocket Lab's revenue trajectory is strongly accelerating, with Q1 2026 revenue of $200.35 million, representing a 63.46% year-over-year growth rate, up from $122.57 million in Q1 2025. This marks the fourth consecutive quarter of accelerating growth, with revenue rising from $104.81 million in Q3 2024 to $179.65 million in Q4 2025, and now to $200.35 million in Q1 2026. The growth is driven by both segments, with Product revenue of $127.49 million and Service revenue of $72.86 million in the latest quarter, reflecting strong demand for launch services and space systems. The company's gross margin has improved to 38.18% in Q1 2026, up from 28.76% in Q1 2025, indicating operational leverage and better cost management, although it remains below industry leaders like SpaceX, which operates at higher margins due to scale.
Quarterly Revenue
$200348000.0B
2026-03
Revenue YoY Growth
+63.5%
YoY Comparison
Gross Margin
38.2%
Latest Quarter
Free Cash Flow
$-316301000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RKLB Overvalued?
Given that Rocket Lab has negative net income (EPS of -$0.07 in Q1 2026), the price-to-sales (PS) ratio is the most appropriate valuation metric, as earnings-based metrics like PE are not meaningful. The current PS ratio is 61.51x, which is extremely high compared to the broader aerospace and defense sector average of around 2-3x, indicating a massive premium. This premium reflects the market's expectations for rapid growth, but it also implies significant risk if the company fails to meet those expectations. The forward PE of 1605x, based on estimated EPS of $0.92, suggests that even on a forward basis, the stock is priced for perfection, with any disappointment likely to lead to a sharp de-rating.
PE
-188.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-234.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are significant: Rocket Lab has negative net income (-$45.02M in Q1 2026) and negative free cash flow (-$316.3M TTM), indicating a reliance on external capital. The debt-to-equity ratio is low at 0.15, but the company's cash burn rate, if sustained, could lead to dilution or increased leverage. Revenue concentration in government contracts (e.g., $397M Space Force deal) adds dependency on a few large customers, and any contract cancellation could materially impact revenue. The gross margin, while improving, is still below industry leaders, and operating margin is deeply negative at -38.03%, showing that the company is far from profitability.